Industry reports
Editor highlights

Pathology

Summary

Table of Contents

Data Series

  • Publication date: July 2013
  • Report size: 165 pages
Keywords : Hodgkin lymphoma, Anaplastic large cell lymphoma, Epstein-Barr Virus

Hodgkin Lymphoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Hodgkin Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hodgkin Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the ...

More »

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Pathology Industry in the United States : Latest Reports

Trypanosomiasis - Pipeline Review, H2 2013

Trypanosomiasis - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Trypanosomiasis - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Trypanosomiasis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

Chronic Urticaria Or Hives - Pipeline Review, H2 2013

Chronic Urticaria Or Hives - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Chronic Urticaria Or Hives - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Chronic Urticaria Or Hives - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. ...

Hemoglobinopathies - Pipeline Review, H2 2013

Hemoglobinopathies - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Hemoglobinopathies - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Hemoglobinopathies - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

Rubella - Pipeline Review, H2 2013

December 2013 $ 2 000

Pathology Industry in the United States : Latest Downloads

Company Report: Pathology for Year 2014

  • Company report
  • April 2014
  • 7 pages

Company Report: Pathology for Year 2014

  • Company report
  • April 2014
  • 6 pages

... For ampyra in stroke, the adaptive design of the phase 2/3 trial should allow acorda to take an interim look at efficacy as measured by 2-min walk distance as well as a scaled efficacy measurement similar ...


Company Profiles

9 Companies

SYNTHES Inc.

Switzerland

Biosense Webster Inc.

United States

Synthes Inc.

United States

General Hospital Corp.

United States

UnitedHealth Group Inc.

United States

Eli Lilly and Co.

United States

Johnson and Johnson

United States

Banner Health

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.